AbCellera Biologics Inc

NASDAQ:ABCL   12:11:30 PM EDT
12.42
-0.59 (-4.54%)
Products, Strategic Combinations

Abcellera And Atlas Venture Collaborate To Empower The Development Of Impactful Medicines For Patients

Published: 08/03/2022 11:20 GMT
AbCellera Biologics Inc (ABCL) - Abcellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients.
Abcellera Biologics - Atlas' Portfolio Company Will Have Right to Develop and Commercialize Therapeutic Antibodies Resulting From Collaboration.
Abcellera Biologics - Will Receive Research Payments, Eligible to Receive Clinical, Commercial Milestone Payments & Royalties on Net Sales of Products.